eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-VRTX-Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated VRTX

433.16-14.02(-3.14%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Vertex Pharmaceuticals Incorporated
Today
Create an eToro account to buy VRTX stock on a secure, user-friendly, multi-asset trading platform.
Buy Vertex Pharmaceuticals Incorporated
Buy Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated VRTX
Buy VRTX
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
514.6
Based on analysts who covered VRTX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

VRTX Stock Price Chart

‎-8.47‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Vertex Pharmaceuticals Incorporated share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Vertex Pharmaceuticals Incorporated share price today is 433.16, reflecting a ‎-3.14‎% change over the last 24 hours and ‎3.48‎% over the past week. The current market capitalization of VRTX is 114.83B with an average volume in the last three months of 1.72M. The stock has a P/E ratio of -114 and a dividend yield of 0%. With the stock’s beta sitting at 0.56
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
114.83B
Day’s Range
i
Shows the high and low prices of the day.
416.17 - 504.42
52W Range
i
Shows the high and low prices of the last year.
341.4 - 518.89
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.72M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-114
Revenue
i
The total income generated by this company’s goods and services last year.
11.04B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
447.18
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-3.92
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.56
What Is Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. The firm was founded in 1989, and its primary focus is on the researching and marketing of biotechnology solutions for the treatment of cystic fibrosis. The company has a number of approved therapies available that are aimed at the treatment of the underlying cause of cystic fibrosis.

The company also operates advanced independent research and development programs in other areas, and has a number of investigational small molecule medicines in their pipeline, aimed at treating kidney diseases, pain, and genetic diseases such as sickle cell disease, Duchenne muscular dystrophy and Type 1 diabetes.

Vertex Pharmaceuticals works in collaboration with Cystic Fibrosis Foundation Therapeutics Incorporated, CRISPR Therapeutics AG, and other organisations, and markets its products mainly to specialty healthcare providers in North America, as well as global government-owned providers. The firm has regularly been ranked as one of the industry's best places to work, including making Science Magazine's Top Employers list for 11 consecutive years, and being named a top place to work for LGBTQ equality by the Human Rights Campaign. The firm trades on the NASDAQ under the ticker VRTX.

Learn more about the share price performance of VRTX on eToro.
Buy VRTX

How can I buy Vertex Pharmaceuticals Incorporated stocks?

To purchase Vertex Pharmaceuticals Incorporated:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Vertex Pharmaceuticals Incorporated (VRTX) page and place an order to buy Vertex Pharmaceuticals Incorporated.
Buy VRTX
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Vertex Pharmaceuticals Incorporated
Invest in Vertex Pharmaceuticals Incorporated
Today
Create an eToro account to buy VRTX stock on a secure, user-friendly, multi-asset trading platform.
Buy VRTX

FAQ

The current price of VRTX is 433.16.
The average price target for Vertex Pharmaceuticals Incorporated is 433.16. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Vertex Pharmaceuticals Incorporated based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Vertex Pharmaceuticals Incorporated is 114.83B
Based on 6 analysts offering recommendations for VRTX in the last 3 months, the overall consensus is Moderate Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top